Antje Willuweit

Dr. Antje Willuweit

Forschungszentrum Juelich GmbH
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1998 in Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
MKMatthias Kalbas
Matthias Kalbas
AWAntje Willuweit
Antje Willuweit
VHVolker Henn
Volker Henn
RKRichard A. Kroczek
Richard A. Kroczek
GMGert Müller-Berghaus
Gert Müller-Berghaus
JSJoseph Slupsky
Joseph Slupsky
Summary: CD40 is a type I member of the tumour necrosis factor (TNF) receptor superfamily of proteins, and is present on a wide variety of cells including vascular endothelial cells. Ligation of this receptor on endothelial cells is known to increase expression of inflammatory adhesion molecules. We have recently demonstrated that platelets express the ligand of CD40 (CD154) within seconds of exposure to agonist, and interact with endothelial cells to participate directly in the induction of an inflammatory response. Here we show that activated platelets induce tissue factor (TF) expression on endothelial cells in a CD40/CD154-dependent manner, and that the magnitude of this response can equal that induced by TNFα. Moreover, CD40 ligation on endothelial cells downregulates the expression of thrombomodulin. We also show that CD40-mediated TF expression is less sensitive to inhibition with the oxidative radical scavenger pyrrolidine dithiocarbamate than is that mediated by TNFα, indicating that CD40 has a distinct signalling pathway. Tissue factor is a cell membrane protein which functions as the main trigger of the extrinsic pathway of blood coagulation, and its expression on endothelial cells is implicated in wound healing and angiogenesis. Since platelets are among the first cells involved in haemostasis following tissue injury, our data showing that ligation of CD40 by CD154 induces a procoagulant phenotype on vascular endothelial cells suggests that platelets may play an important role in the induction of wound healing.

2 June 2010 in Genes, Brain and Behavior
Verified
Journal Article
Closed access
PDF file
SKS. Krackow
S. Krackow
EVE. Vannoni
E. Vannoni
ACA. Codita
A. Codita
AMA. H. Mohammed
A. H. Mohammed
FCFrancesca Cirulli
Francesca Cirulli
HLH.‐P. Lipp
H.‐P. Lipp

9 March 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AMAndré Manook
André Manook
BYBehrooz H Yousefi
Behrooz H Yousefi
AWAntje Willuweit
Antje Willuweit
SPStefan Platzer
Stefan Platzer
SRSybille Reder
Sybille Reder
ADAlexander Drzezga
Alexander Drzezga
In vivo imaging and quantification of amyloid-β plaque (Aβ) burden in small-animal models of Alzheimer's disease (AD) is a valuable tool for translational research such as developing specific imaging markers and monitoring new therapy approaches. Methodological constraints such as image resolution of positron emission tomography (PET) and lack of suitable AD models have limited the feasibility of PET in mice. In this study, we evaluated a feasible protocol for PET imaging of Aβ in mouse brain with [11C]PiB and specific activities commonly used in human studies. In vivo mouse brain MRI for anatomical reference was acquired with a clinical 1.5 T system. A recently characterized APP/PS1 mouse was employed to measure Aβ at different disease stages in homozygous and hemizygous animals. We performed multi-modal cross-validations for the PET results with ex vivo and in vitro methodologies, including regional brain biodistribution, multi-label digital autoradiography, protein quantification with ELISA, fluorescence microscopy, semi-automated histological quantification and radioligand binding assays. Specific [11C]PiB uptake in individual brain regions with Aβ deposition was demonstrated and validated in all animals of the study cohort including homozygous AD animals as young as nine months. Corresponding to the extent of Aβ pathology, old homozygous AD animals (21 months) showed the highest uptake followed by old hemizygous (23 months) and young homozygous mice (9 months). In all AD age groups the cerebellum was shown to be suitable as an intracerebral reference region. PET results were cross-validated and consistent with all applied ex vivo and in vitro methodologies. The results confirm that the experimental setup for non-invasive [11C]PiB imaging of Aβ in the APP/PS1 mice provides a feasible, reproducible and robust protocol for small-animal Aβ imaging. It allows longitudinal imaging studies with follow-up periods of approximately one and a half years and provides a foundation for translational Alzheimer neuroimaging in transgenic mice.

1 November 2017 in Methods
Verified
Journal Article
Closed access
KLKarl-Josef Langen
Karl-Josef Langen
GSGabriele Stoffels
Gabriele Stoffels
CFChristian Filss
Christian Filss
AHAlexander Heinzel
Alexander Heinzel
CSCarina Stegmayr
Carina Stegmayr
NGNorbert Galldiks
Norbert Galldiks

1 November 2000 in European Journal of Cell Biology
Verified
Journal Article
Closed access
MHMatthias Heil
Matthias Heil
Matthias ClaussMatthias Clauss
Matthias Clauss
KSKeisuke Suzuki
Keisuke Suzuki
IBIvo R. Buschmann
Ivo R. Buschmann
AWAntje Willuweit
Antje Willuweit
WSWolfgang Schaper
Wolfgang Schaper

1 September 2001 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SBSabine Blum
Sabine Blum
KIKatja Issbrüker
Katja Issbrüker
AWAntje Willuweit
Antje Willuweit
SHStephanie Hehlgans
Stephanie Hehlgans
MLMarkus Lucerna
Markus Lucerna
Matthias ClaussMatthias Clauss
Matthias Clauss
Vascular endothelial growth factor (VEGF) is not only essential for vasculogenesis and angiogenesis but is also capable of inducing tissue factor, the prime initiator of coagulation, in endothelial cells. In this study we have analyzed the VEGF-elicited pathways involved in the induction of tissue factor in human umbilical cord vein endothelial cells. Using specific low molecular weight inhibitors we could demonstrate a crucial role of the p38 and Erk-1/2 mitogen-activated protein (MAP) kinases. In contrast, treatment with wortmannin or LY294002, inhibitors of phosphatidylinositol 3 (PI3)-kinase, resulted in a strong enhancement of the VEGF-induced tissue factor production, indicating a negative regulatory role of the PI3-kinase on tissue factor-inducing pathways. Accordingly, transduction with constitutively active Akt led to a reduction of VEGF-induced tissue factor production. Western blot analyses using antibodies specific for phosphorylated p38 showed an enhanced activation of this MAP kinase in human umbilical cord vein endothelial cells when stimulated with VEGF in the presence of wortmannin in comparison to either agent alone. Thus, the negative regulation of the PI3-kinase pathway on endothelial tissue factor activity can be explained at least in part by a suppression of this MAP kinase-signaling pathway. This is the first demonstration of a reciprocal relationship between procoagulant activity and the PI3-kinase-Akt signaling pathway, and it reveals a novel mechanism by which tissue factor expression can be controlled in endothelial cells.